805 related articles for article (PubMed ID: 25424794)
21. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.
Tsai HY; Chen YH; Liao CH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Int J Antimicrob Agents; 2013 Oct; 42(4):312-6. PubMed ID: 23849332
[TBL] [Abstract][Full Text] [Related]
22. European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.
Navarro Torné A; Dias JG; Quinten C; Hruba F; Busana MC; Lopalco PL; Gauci AJ; Pastore-Celentano L;
Vaccine; 2014 Jun; 32(29):3644-50. PubMed ID: 24795228
[TBL] [Abstract][Full Text] [Related]
23. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009.
Ho PL; Chiu SS; Ang I; Lau YL
Vaccine; 2011 Apr; 29(17):3270-5. PubMed ID: 21352937
[TBL] [Abstract][Full Text] [Related]
24. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
25. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
[TBL] [Abstract][Full Text] [Related]
26. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG;
J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
28. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates.
Ozawa D; Yano H; Endo S; Hidaka H; Kakuta R; Okitsu N; Kanamori H; Ogawa M; Ichimura S; Shimojima M; Inomata S; Kaku M; Katori Y
Pediatr Infect Dis J; 2015 Sep; 34(9):e217-21. PubMed ID: 26083590
[TBL] [Abstract][Full Text] [Related]
29. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
[TBL] [Abstract][Full Text] [Related]
30. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
31. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
[TBL] [Abstract][Full Text] [Related]
32. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain.
Fenoll A; Aguilar L; Giménez MJ; Vicioso MD; Robledo O; Granizo JJ; Coronel P
Int J Antimicrob Agents; 2012 Jul; 40(1):18-23. PubMed ID: 22578763
[TBL] [Abstract][Full Text] [Related]
33. Pneumococcal serotype distribution and antibiotic susceptibility in Malaysia: A four-year study (2014-2017) on invasive paediatric isolates.
Arushothy R; Ahmad N; Amran F; Hashim R; Samsudin N; Azih CRC
Int J Infect Dis; 2019 Mar; 80():129-133. PubMed ID: 30572022
[TBL] [Abstract][Full Text] [Related]
34. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
Lee JK; Yun KW; Choi EH; Kim SJ; Lee SY; Lee HJ
J Korean Med Sci; 2017 Sep; 32(9):1431-1439. PubMed ID: 28776337
[TBL] [Abstract][Full Text] [Related]
35. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years.
Liu Y; Wang H; Chen M; Sun Z; Zhao R; Zhang L; Wang H; Zhang H; Wang L; Chu Y; Liu Y; Ni Y
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):256-63. PubMed ID: 18358662
[TBL] [Abstract][Full Text] [Related]
36. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
Imöhl M; Reinert RR; van der Linden M
Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
[TBL] [Abstract][Full Text] [Related]
37. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014.
Kim SH; Bae IK; Park D; Lee K; Kim NY; Song SA; Kim HR; Jeon GW; Urm SH; Shin JH
Biomed Res Int; 2016; 2016():6950482. PubMed ID: 27314035
[TBL] [Abstract][Full Text] [Related]
38. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
[TBL] [Abstract][Full Text] [Related]
39. Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.
Mendes RE; Costello AJ; Jacobs MR; Biek D; Critchley IA; Jones RN
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):19-25. PubMed ID: 24974272
[TBL] [Abstract][Full Text] [Related]
40. Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness.
Yildirim I; Little BA; Finkelstein J; Lee G; Hanage WP; Shea K; Pelton SI; ;
Vaccine; 2017 Jul; 35(32):4002-4009. PubMed ID: 28645717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
